AU2001252650A1 - Novel derivative of cell chemotactic factor - Google Patents

Novel derivative of cell chemotactic factor

Info

Publication number
AU2001252650A1
AU2001252650A1 AU2001252650A AU5265001A AU2001252650A1 AU 2001252650 A1 AU2001252650 A1 AU 2001252650A1 AU 2001252650 A AU2001252650 A AU 2001252650A AU 5265001 A AU5265001 A AU 5265001A AU 2001252650 A1 AU2001252650 A1 AU 2001252650A1
Authority
AU
Australia
Prior art keywords
chemotactic factor
novel derivative
cell chemotactic
cell
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252650A
Inventor
Shiro Kanegasaki
Hiroshi Maeda
Kouji Matsushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Effector Cell Institute Inc
Original Assignee
Effector Cell Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Effector Cell Institute Inc filed Critical Effector Cell Institute Inc
Publication of AU2001252650A1 publication Critical patent/AU2001252650A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001252650A 2000-04-28 2001-04-27 Novel derivative of cell chemotactic factor Abandoned AU2001252650A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000131179 2000-04-28
JP2000-131179 2000-04-28
PCT/JP2001/003727 WO2001083548A1 (en) 2000-04-28 2001-04-27 Novel derivative of cell chemotactic factor

Publications (1)

Publication Number Publication Date
AU2001252650A1 true AU2001252650A1 (en) 2001-11-12

Family

ID=18640126

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252650A Abandoned AU2001252650A1 (en) 2000-04-28 2001-04-27 Novel derivative of cell chemotactic factor

Country Status (2)

Country Link
AU (1) AU2001252650A1 (en)
WO (1) WO2001083548A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004196770A (en) * 2002-10-24 2004-07-15 Effector Cell Institute Inc Agent for increasing blood level of dendritic cell precursor
CN101119743B (en) 2005-01-31 2012-09-26 株式会社Eci Immunopotentiating agent
ES2653790T3 (en) * 2005-08-05 2018-02-08 Araim Pharmaceuticals, Inc. Protective tissue peptides and uses thereof
MX2010008050A (en) 2008-01-22 2011-02-23 Araim Pharmaceuticals Inc Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6075432A (en) * 1983-08-08 1985-04-27 Kuraray Co Ltd Neocarzinostatin derivative and production thereof
JPH1160499A (en) * 1997-08-22 1999-03-02 Hiroshi Maeda Antitumor agent

Also Published As

Publication number Publication date
WO2001083548A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU2002218266A1 (en) Novel indanylidene compounds
EP1130098A3 (en) Mammalian osteoregulins
AU2002216399A1 (en) Synovial cell protein
AU2001292518A1 (en) Novel compounds
AU2001265089A1 (en) Rc-timer scheme
AU2000223275A1 (en) Novel triazole derivatives
AU2001239765A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU2002231077A1 (en) Novel compounds
AU2001256964A1 (en) Novel compounds
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001272242A1 (en) Portable incubator
AU2001275897A1 (en) Improvement of cell culture performance
AU2001252650A1 (en) Novel derivative of cell chemotactic factor
AU2001230689A1 (en) Novel compounds
AU2002216060A1 (en) Novel compounds
AU2002221923A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2001246243A1 (en) Planar transformer
AU2001288484A1 (en) Novel metallotexaphyrin derivatives
AU2002219846A1 (en) Novel use
AU2001237533A1 (en) Novel p-gp-inhibiting compounds